Evidence map›Paper›PMID 40341429›Full record

ReviewApplied microbiology and biotechnology2025

Activity assays for flavoprotein oxidases: an overview.

Lars L Santema, Marco W Fraaije

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lars L SantemaMolecular Enzymology, University of Groningen, Nijenborgh 3, 9747 AG, Groningen, The Netherlands.
Marco W FraaijeMolecular Enzymology, University of Groningen, Nijenborgh 3, 9747 AG, Groningen, The Netherlands. m.w.fraaije@rug.nl.ORCID http://orcid.org/0000-0001-6346-5014

Funding

European Union's Horizon 2020 research and innovation program under Grant Agreement 101000607 Grant Agreement 101000607
6 · The paper itself

Abstract

Flavoprotein oxidases have found many biotechnological applications. For identifying and improving their characteristics, it is essential to have reliable and robust assay methodology available. The methodologies used to monitor their activity seem to be scattered in the literature and seem often selected based on convenience. Due to the diversity of reactions catalyzed by flavoprotein oxidases, it is virtually impossible to recommend a single activity assay. A literature analysis of 60 recent papers describing flavoprotein oxidases revealed that continuous spectrophotometric assays, in particular colorimetric assays, are the preferred choice, as they are facile, scalable and allow for better interpretation of data than discontinuous assays. Colorimetric assays typically rely on the extinction coefficient of a monitored chromogenic product, which can be highly variable depending on the experimental conditions. Therefore, it is important to determine the extinction coefficient under the specific experimental conditions used, rather than taking it directly from the literature. To provide a guideline and assist in standardization, this review describes the most commonly utilized activity assays for flavoprotein oxidases, along with their respective merits and limitations. KEY POINTS: • Researchers should be more aware of limitations of activity assays. • Extinction coefficients should be determined for the appropriate experimental setup. • New robust activity assays are desired.

Indexed as

Enzyme AssaysFlavoproteinsOxidoreductasesColorimetrySpectrophotometryFlavoproteinsOxidoreductasesChromogenic assaysElectrochemical assaysHorseradish peroxidaseOxidase activity assaysPhotometric assays

Identifiers

PMID40341429
PMCPMC12062150

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.